Despite the genetic heterogeneity of osteosarcoma, we thus identified systematic alterations of RNA-binding proteins in patient-derived osteosarcoma cells that may function as oncogenic or tumor-suppressive proteins. Here, RBMS3 is linked to neoplasm.